Skip to main content

Provider

By Mallory Hackett | 01:37 pm | October 28, 2020
The most common distractions were surfing the web, checking email or texting, with more than 24% of respondents admitting being distracted by these.
By Sara Mageit | 06:52 am | October 28, 2020
The nasal swab test device returns results in 12 minutes.
By Sara Mageit | 06:18 am | October 28, 2020
New study finds that as the pandemic accelerates regulatory acceptance, the market value is expected to grow by 865% over the next five years.
By Sophie Porter | 03:47 am | October 28, 2020
The funding was led by ETF and an investor consortium from across AI, science and analytics.
By Tammy Lovell | 03:23 am | October 28, 2020
The proceeds will be used to drive product development and expand operations in the US.
By Mallory Hackett | 03:37 pm | October 27, 2020
College campuses have proven to be hotbeds for infection of COVID-19 since the pandemic began.
By Dave Muoio | 03:08 pm | October 27, 2020
Following news that its Project Baseline program was poorly received in parts of the Bay Area, the life science company characterized site closures as more of a pause and a redirection of resources across the state.
By Sara Mageit | 09:39 am | October 27, 2020
Fortunis Capital has awarded Clementine a place in its top 20 UK Impact Investment Fund.
By Sophie Porter | 03:51 am | October 27, 2020
EIS fund manager Parkwalk led the funding round alongside existing investors Jonathon Milner, Cambridge Enterprise and Martlet.
By Dave Muoio | 04:14 pm | October 26, 2020
Researchers say that their tool detected cases with 79% accuracy, and did so within minutes.